{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T06:05:45Z","timestamp":1785477945143,"version":"3.56.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.idc.2020.10.006","type":"journal-article","created":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T19:02:58Z","timestamp":1607367778000},"page":"169-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Skin and Soft Tissue Infections in Persons Who Inject Drugs"],"prefix":"10.1016","volume":"35","author":[{"given":"Henry F.","family":"Chambers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.idc.2020.10.006_bib1","doi-asserted-by":"crossref","first-page":"e97596","DOI":"10.1371\/journal.pone.0097596","article-title":"Estimating the number of persons who inject drugs in the United States by meta-analysis to calculate national rates of HIV and hepatitis C virus infections","volume":"9","author":"Lansky","year":"2014","journal-title":"PLoS One"},{"issue":"1\u20133","key":"10.1016\/j.idc.2020.10.006_bib2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.drugalcdep.2010.11.025","article-title":"Correlates of risky injection practices among past-year injection drug users among the US general population","volume":"116","author":"Ropelewski","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.idc.2020.10.006_bib4","doi-asserted-by":"crossref","first-page":"107695","DOI":"10.1016\/j.drugalcdep.2019.107695","article-title":"Self-treatment of skin infections by people who inject drugs","volume":"206","author":"Monteiro","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.idc.2020.10.006_bib5","first-page":"95","article-title":"Needles and the damage done: reasons for admission and financial costs associated with injecting drug use in a Central London Teaching Hospital","volume":"66","author":"Marks","year":"2013","journal-title":"J\u00a0Infect"},{"issue":"4","key":"10.1016\/j.idc.2020.10.006_bib6","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s11414-009-9177-z","article-title":"US hospitalizations and costs for illicit drug users with soft tissue infections","volume":"37","author":"Takahashi","year":"2010","journal-title":"J\u00a0Behav Health Serv Res"},{"issue":"8","key":"10.1016\/j.idc.2020.10.006_bib7","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1086\/656431","article-title":"Skin and soft-tissue infections requiring hospitalization at an academic medical center: opportunities for antimicrobial stewardship","volume":"51","author":"Jenkins","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2020.10.006_bib8","doi-asserted-by":"crossref","first-page":"e0196944","DOI":"10.1371\/journal.pone.0196944","article-title":"Both localized and systemic bacterial infections are predicted by injection drug use: a prospective follow-up study in Swedish criminal justice clients","volume":"13","author":"Dahlman","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.idc.2020.10.006_bib9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s15010-004-3106-0","article-title":"Staphylococcus aureus infections in injection drug users: risk factors and prevention strategies","volume":"32","author":"Bassetti","year":"2004","journal-title":"Infection"},{"issue":"3","key":"10.1016\/j.idc.2020.10.006_bib10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1128\/CMR.10.3.505","article-title":"Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks","volume":"10","author":"Kluytmans","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.idc.2020.10.006_bib11","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.3389\/fmicb.2018.02419","article-title":"Staphylococcus aureus nasal colonization: an update on mechanisms, epidemiology, risk factors, and subsequent infections","volume":"9","author":"Sakr","year":"2018","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.idc.2020.10.006_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1086\/320879","article-title":"Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study","volume":"33","author":"Murphy","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2020.10.006_bib13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/cid\/ciz818","article-title":"Frequent methicillin-resistant Staphylococcus aureus introductions into an inner-city jail: indications of Community Transmission Networks","volume":"71","author":"Popovich","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2020.10.006_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01622-15","article-title":"Methamphetamine alters the antimicrobial efficacy of phagocytic cells during methicillin-resistant Staphylococcus aureus skin infection","volume":"6","author":"Mihu","year":"2015","journal-title":"mBio"},{"issue":"3","key":"10.1016\/j.idc.2020.10.006_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.drugpo.2008.08.003","article-title":"Heroin in brown, black and white: structural factors and medical consequences in the US heroin market","volume":"20","author":"Ciccarone","year":"2009","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.idc.2020.10.006_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.drugpo.2016.08.006","article-title":"Injection-site vein loss and soft tissue abscesses associated with black tar heroin injection: a cross-sectional study of two distinct populations in USA","volume":"39","author":"Summers","year":"2017","journal-title":"Int J Drug Policy"},{"issue":"9","key":"10.1016\/j.idc.2020.10.006_bib17","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1086\/383471","article-title":"Outbreak of necrotizing fasciitis due to Clostridium sordellii among black-tar heroin users","volume":"38","author":"Kimura","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2020.10.006_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/08897077.2016.1263592","article-title":"Behavioral characteristics and injection practices associated with skin and soft tissue infections among people who inject drugs: a community-based observational study","volume":"38","author":"Dahlman","year":"2017","journal-title":"Subst Abus"},{"issue":"6","key":"10.1016\/j.idc.2020.10.006_bib19","first-page":"461","article-title":"Risk factors associated with skin and soft tissue infections among hospitalized people who inject drugs","volume":"11","author":"Phillips","year":"2017","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.idc.2020.10.006_bib20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1747-597X-8-32","article-title":"Assisted injection among people who inject drugs in Thailand","volume":"8","author":"Lee","year":"2013","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"3","key":"10.1016\/j.idc.2020.10.006_bib21","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1086\/313703","article-title":"High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco","volume":"30","author":"Binswanger","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2020.10.006_bib22","first-page":"87","article-title":"High rates of abscesses and chronic wounds in community-recruited injection drug users and associated risk factors","volume":"9","author":"Smith","year":"2015","journal-title":"J\u00a0Addict Med"},{"issue":"1","key":"10.1016\/j.idc.2020.10.006_bib23","first-page":"127","article-title":"Type and location of injection drug use-related soft tissue infections predict hospitalization","volume":"80","author":"Takahashi","year":"2003","journal-title":"J\u00a0Urban Health"},{"key":"10.1016\/j.idc.2020.10.006_bib24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1477-7517-2-24","article-title":"Prevalence and correlates of abscesses among a cohort of injection drug users","volume":"2","author":"Lloyd-Smith","year":"2005","journal-title":"Harm Reduct J"},{"issue":"7","key":"10.1016\/j.idc.2020.10.006_bib25","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3109\/10826084.2013.787094","article-title":"Abscess and self-treatment among injection drug users at four California syringe exchanges and their surrounding communities","volume":"48","author":"Fink","year":"2013","journal-title":"Subst Use Misuse"},{"issue":"3","key":"10.1016\/j.idc.2020.10.006_bib26","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.annemergmed.2019.02.002","article-title":"Effect of initial bedside ultrasonography on emergency department skin and soft tissue infection management","volume":"74","author":"Mower","year":"2019","journal-title":"Ann Emerg Med"},{"issue":"1","key":"10.1016\/j.idc.2020.10.006_bib27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.idc.2007.12.001","article-title":"Management of skin and soft-tissue infections in the emergency department","volume":"22","author":"Abrahamian","year":"2008","journal-title":"Infect Dis Clin North Am"},{"issue":"2","key":"10.1016\/j.idc.2020.10.006_bib28","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2020.10.006_bib29","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.ajem.2017.05.039","article-title":"Low yield of blood and wound cultures in patients with skin and soft-tissue infections","volume":"35","author":"Torres","year":"2017","journal-title":"Am J Emerg Med"},{"issue":"8","key":"10.1016\/j.idc.2020.10.006_bib30","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/acem.12727","article-title":"Microbiology and initial antibiotic therapy for injection drug users and non-injection drug users with cutaneous abscesses in the era of community-associated methicillin-resistant Staphylococcus aureus","volume":"22","author":"Jenkins","year":"2015","journal-title":"Acad Emerg Med"},{"issue":"9","key":"10.1016\/j.idc.2020.10.006_bib31","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMoa1507476","article-title":"Trimethoprim-sulfamethoxazole versus placebo for uncomplicated skin abscess","volume":"374","author":"Talan","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.idc.2020.10.006_bib32","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa1607033","article-title":"DMID 07-0051 team. a placebo-controlled trial of antibiotics for smaller skin abscesses","volume":"376","author":"Daum","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.idc.2020.10.006_bib33","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1128\/AAC.00206-07","article-title":"Prospective randomized trial of empiric therapy with trimethoprim- sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus","volume":"51","author":"Cenizal","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.idc.2020.10.006_bib34","doi-asserted-by":"crossref","first-page":"ofv178","DOI":"10.1093\/ofid\/ofv178","article-title":"Minocycline as A substitute for doxycycline in targeted scenarios: a systematic review","volume":"2","author":"Carris","year":"2015","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2020.10.006_bib35","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/jama.2012.8262","article-title":"Does this adult patient with suspected bacteremia require blood cultures?","volume":"308","author":"Coburn","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.idc.2020.10.006_bib36","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejim.2016.07.029","article-title":"Blood cultures in the evaluation of uncomplicated cellulitis","volume":"36","author":"Bauer","year":"2016","journal-title":"Eur J Intern Med"},{"issue":"4","key":"10.1016\/j.idc.2020.10.006_bib37","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10096-019-03490-6","article-title":"Adherence to antibiotic guidelines for erysipelas or cellulitis is associated with a favorable outcome","volume":"38","author":"Klotz","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2020.10.006_bib38","first-page":"148","article-title":"A\u00a0systematic review of bacteremias in cellulitis and erysipelas","volume":"64","author":"Gunderson","year":"2012","journal-title":"J\u00a0Infect"},{"issue":"11","key":"10.1016\/j.idc.2020.10.006_bib39","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1093\/cid\/civ655","article-title":"EMERGEncy ID Net Study Group. Inability of polymerase chain reaction, pyrosequencing, and culture of infected and uninfected site skin biopsy specimens to identify the cause of cellulitis","volume":"61","author":"Crisp","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2020.10.006_bib40","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJMoa1403789","article-title":"DMID 07-0051 Team. Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections","volume":"372","author":"Miller","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.idc.2020.10.006_bib41","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1001\/jama.2017.5653","article-title":"Effect of cephalexin plus trimethoprim-sulfamethoxazole vs cephalexin alone on clinical cure of uncomplicated cellulitis: a randomized clinical trial","volume":"317","author":"Moran","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.idc.2020.10.006_bib42","doi-asserted-by":"crossref","first-page":"108057","DOI":"10.1016\/j.drugalcdep.2020.108057","article-title":"Incidence and treatment costs of severe bacterial infections among people who inject heroin: a cohort study in South London","volume":"212","author":"Lewer","year":"2020","journal-title":"Engl Drug Alcohol Depend"},{"issue":"8","key":"10.1016\/j.idc.2020.10.006_bib43","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/archsurg.133.8.812","article-title":"Necrotizing soft tissue infection masquerading as cutaneous abscess following illicit drug injection","volume":"133","author":"Callahan","year":"1998","journal-title":"Arch Surg"},{"issue":"23","key":"10.1016\/j.idc.2020.10.006_bib44","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1056\/NEJMra1600673","article-title":"Necrotizing soft-tissue infections","volume":"377","author":"Stevens","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"1088","key":"10.1016\/j.idc.2020.10.006_bib45","doi-asserted-by":"crossref","first-page":"20180093","DOI":"10.1259\/bjr.20180093","article-title":"Necrotizing fasciitis of the lower extremity: imaging pearls and pitfalls","volume":"91","author":"Tso","year":"2018","journal-title":"Br J Radiol"},{"issue":"14","key":"10.1016\/j.idc.2020.10.006_bib46","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMoa042683","article-title":"Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles","volume":"352","author":"Miller","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.idc.2020.10.006_bib47","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1556-4029.2007.00452.x","article-title":"Necrotizing fasciitis: manifestations, microbiology and connection with black tar heroin","volume":"52","author":"Dunbar","year":"2007","journal-title":"J\u00a0Forensic Sci"},{"issue":"7","key":"10.1016\/j.idc.2020.10.006_bib48","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/cid\/ciw871","article-title":"Impact of intravenous immunoglobulin on survival in necrotizing fasciitis with vasopressor-dependent shock: a propensity score-matched analysis from 130\u00a0US hospitals","volume":"64","author":"Kadri","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2020.10.006_bib49","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1093\/cid\/ciy401","article-title":"Polyspecific intravenous immunoglobulin in clindamycin-treated patients with streptococcal toxic shock syndrome: a systematic review and meta-analysis","volume":"67","author":"Parks","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2020.10.006_bib50","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1001\/archinte.162.5.517","article-title":"Clostridial myonecrosis cluster among injection drug users: a molecular epidemiology investigation","volume":"162","author":"Bangsberg","year":"2002","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.idc.2020.10.006_bib51","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0891-5520(02)00017-X","article-title":"Skin and soft tissue infections in injection drug users","volume":"16","author":"Ebright","year":"2002","journal-title":"Infect Dis Clin North Am"},{"issue":"6","key":"10.1016\/j.idc.2020.10.006_bib52","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.amjmed.2004.03.031","article-title":"Bacterial pyomyositis in the United States","volume":"117","author":"Crum","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.idc.2020.10.006_bib53","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.anaerobe.2014.09.005","article-title":"View from the front lines: an emergency medicine perspective on clostridial infections in injection drug users","volume":"30","author":"Gonzales y Tucker","year":"2014","journal-title":"Anaerobe"},{"issue":"11","key":"10.1016\/j.idc.2020.10.006_bib54","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.5858\/2003-127-1465-AFIAOO","article-title":"Autopsy findings in an outbreak of severe systemic illness in heroin users following injection site inflammation: an effect of Clostridium novyi exotoxin?","volume":"127","author":"Finn","year":"2003","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.idc.2020.10.006_bib55","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1017\/S0950268805003845","article-title":"Soft tissue infections caused by spore-forming bacteria in injecting drug users in the United Kingdom","volume":"133","author":"Brett","year":"2005","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.idc.2020.10.006_bib56","author":"Faulkner"},{"issue":"5","key":"10.1016\/j.idc.2020.10.006_bib57","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1089\/sur.2019.244","article-title":"Fatal necrotizing soft-tissue infection caused by Clostridium tetani in an injecting drug user: a case report","volume":"21","author":"Cardinal","year":"2020","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.idc.2020.10.006_bib58","author":"Centers for Disease Control and Prevention"},{"issue":"2","key":"10.1016\/j.idc.2020.10.006_bib59","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1155\/2015\/482309","article-title":"A\u00a0cluster of Bacillus cereus bacteremia cases among injection drug users","volume":"26","author":"Benusic","year":"2015","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"9","key":"10.1016\/j.idc.2020.10.006_bib60","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.3201\/eid2209.150647","article-title":"Persistent Bacillus cereus Bacteremia in 3 Persons Who Inject Drugs, San Diego, California, USA","volume":"22","author":"Schaefer","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2020.10.006_bib61","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1007\/s00134-012-2541-0","article-title":"An overview of anthrax infection including the recently identified form of disease in injection drug users","volume":"38","author":"Hicks","year":"2012","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.idc.2020.10.006_bib62","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-201921","article-title":"Severe systemic Bacillus anthracis infection in an intravenous drug user","volume":"2014","author":"Veitch","year":"2014","journal-title":"BMJ Case Rep"},{"issue":"7","key":"10.1016\/j.idc.2020.10.006_bib63","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1128\/JCM.00362-11","article-title":"Cutaneous diphtheria in the urban poor population of Vancouver, British Columbia, Canada: a 10-year review","volume":"49","author":"Lowe","year":"2011","journal-title":"J\u00a0Clin Microbiol"},{"issue":"10","key":"10.1016\/j.idc.2020.10.006_bib64","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/archderm.143.10.1305","article-title":"Injection drug use: an understudied cause of venous disease","volume":"143","author":"Pieper","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.idc.2020.10.006_bib65","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1477-7517-11-22","article-title":"Prevalence of skin problems and leg ulceration in a sample of young injecting drug users","volume":"11","author":"Coull","year":"2014","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.idc.2020.10.006_bib66","first-page":"1902","article-title":"Venous leg ulcers","volume":"2008","author":"Nelson","year":"2008","journal-title":"BMJ Clin Evid"},{"key":"10.1016\/j.idc.2020.10.006_bib67","first-page":"1902","article-title":"Venous leg ulcers","volume":"2016","author":"Nelson","year":"2016","journal-title":"BMJ Clin Evid"},{"issue":"1","key":"10.1016\/j.idc.2020.10.006_bib68","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ije\/dyt243","article-title":"Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis","volume":"43","author":"Aspinall","year":"2014","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.idc.2020.10.006_bib69","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12889-017-4210-2","article-title":"Effectiveness of needle and syringe Programmes in people who inject drugs - an overview of systematic reviews","volume":"17","author":"Fernandes","year":"2017","journal-title":"BMC Public Health"},{"issue":"9","key":"10.1016\/j.idc.2020.10.006_bib70","article-title":"Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs","volume":"9","author":"Platt","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.idc.2020.10.006_bib71","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/add.14519","article-title":"Evaluating the cost- effectiveness of existing needle and syringe programmes in preventing hepatitis C transmission in people who inject drugs","volume":"114","author":"Sweeney","year":"2019","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.idc.2020.10.006_bib72","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/add.13593","article-title":"Effectiveness of pharmacy-based needle\/syringe exchange programme for people who inject drugs: a systematic review and meta-analysis","volume":"112","author":"Sawangjit","year":"2017","journal-title":"Addiction"},{"issue":"10","key":"10.1016\/j.idc.2020.10.006_bib73","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1080\/10826080701204763","article-title":"The damage done: a study of injection drug use, injection related abscesses and needle exchange regulation","volume":"42","author":"Tomolillo","year":"2007","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.idc.2020.10.006_bib74","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.drugalcdep.2017.01.020","article-title":"Association between harm reduction intervention uptake and skin and soft tissue infections among people who inject drugs","volume":"174","author":"Dunleavy","year":"2017","journal-title":"Drug Alcohol Depend"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552020300854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552020300854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:19:05Z","timestamp":1760195945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552020300854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0891552020300854"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2020.10.006","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin and Soft Tissue Infections in Persons Who Inject Drugs","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2020.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}